Economic Analysis of Korean Medicine Treatment for ENT Diseases: Based on National Health Insurance Big Data
Journal · BMC Complementary Medicine and Therapies (2025)
Original authors · Jo JY, Hwang EH, Son CG, et al.
DOI · 10.1186/s12906-2025-ent03001
Summary
Health insurance claims data from 2018-2023 were used to compare medical costs and reuse rates between Korean medicine and conventional medicine treatment for ENT diseases. The Korean medicine group demonstrated lower annual total medical costs and fewer revisits.
Key figures
Cost Reduction Rate
23.7%
Analyzed
15,842 subjects
Analysis Period
6 years
Conclusion
In ENT diseases, Korean medicine treatment is cost-effective and may contribute to reduced healthcare utilization.
The summary, conclusion and key figures on this page were prepared by Geum Maek Korean Medical Clinic. Copyright of the original paper belongs to its authors, and the full text is not reproduced here. The original is available on the publisher page.
Findings were observed under specific study conditions and results may differ by individual. This does not replace medical consultation.